$35M Growth Capital Boost for Monteris Medical's Neurosurgical Tech
Event summary
- Trinity Capital Inc. committed $35M in growth capital to Monteris Medical on March 12, 2026.
- Monteris Medical develops the NeuroBlate System, a robotically controlled laser interstitial thermal therapy (LITT) platform for minimally invasive neurosurgery.
- Funding will support commercialization of the NeuroBlate System and expansion of clinical research programs.
- Trinity Capital has deployed over $5.5B across 463 investments since inception in 2008.
The big picture
Trinity Capital's $35M investment in Monteris Medical underscores the growing interest in minimally invasive neurosurgical technologies. The deal highlights the strategic importance of advancing treatment options for brain tumors, radiation necrosis, and drug-resistant epilepsy. With over $5.5B deployed across various sectors, Trinity Capital's backing signals confidence in the scalability and market potential of the NeuroBlate System.
What we're watching
- Commercial Expansion
- How Monteris Medical will leverage the $35M capital to accelerate the commercialization of the NeuroBlate System.
- Clinical Impact
- The pace at which Monteris Medical can expand its clinical research programs and demonstrate the efficacy of its technology.
- Market Penetration
- Whether Monteris Medical can sustain its growth and gain broader adoption across leading neuroscience centers.
Related topics